Is Elevation Oncology, Inc. (ELEV) a Buy, Sell, or Hold?
NASDAQ : ELEV
Elevation Oncology, Inc. — Analyst Ratings
$0.365 USD
-$0.01 (-2.12%)
- Volume
- 4.82M
- Average Volume
- 1.35M
- Market Capitalization
- $21.63M
- P/E Ratio
- -0.47
- Dividend Yield
- 0.00%
- Price Target
- $9.00
- Year High
- $3.09
- Year Low
- $0.22
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $21.21
Analyst Consensus Summary
Consensus Rating
N/A
12 Analysts
Rating Score
0/5
Recommendation Strength
Upside/Downside
-95.9%
vs Current Price
Price Target
$9.00
Average TargetPrice Target Range
Lowest Target
$8.00
-95.4% DOWNSIDE
Average Target
$9.00
Median Estimate
Highest Target
$10.00
-96.4% DOWNSIDEAnalyst Breakdown
Overall Consensus: Hold | Total Analysts: 12
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 3 | 8 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Piper Sandler | Biren Amin | $10 | $4.07 | 2024-05-31 01:03 AM | 145.7% |
| Stephens | Sudan Loganathan | $8 | $3.54 | 2024-05-13 12:35 PM | 126.0% |